FCF Yield
Updated 31h ago
Sector Performance
6th percentileMRNA
-8.3%
Sector Median
4.2%
Sector Avg
7.7%
Deep Analysis
MRNA's free cash flow (FCF) yield of -8.3% means the company is burning cash relative to its market value — for every $100 of market cap, it spends $8.30 more than it generates from operations.
This is well below the sector median of 4.2%, placing it in the 5th percentile among peers, indicating severe underperformance in cash generation. Although the 8-quarter trend direction shows the metric generally increasing (improving from a -18.0% low), the year-over-year change of -1.2% and quarter-over-quarter change of -22.1% both signal recent deterioration. The combination of a deeply negative FCF yield and a worsening near-term trend elevates investment risk, as cash burn is accelerating rather than stabilizing. This directly supports the overall CAUTIOUS verdict — the metric highlights persistent and worsening cash-flow weakness that justifies caution.
Frequently Asked Questions
What does the FCF Yield tell investors about MRNA?
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
How is the FCF Yield calculated?
FCF Yield is calculated as: Free Cash Flow / Market Cap.
Who are MRNA's closest peers by FCF Yield?
The closest peers by FCF Yield include: FMC (-12.9%), NCLH (-13.0%), XEL (-13.6%), SG (-13.6%), GS (-14.0%).
The Formula
Free Cash Flow / Market Cap
Why It Matters
One of the purest measures of value. High FCF yield means the company generates a lot of cash relative to its price — favoured by value investors.
Master MRNA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MRNA research report →MRNA
-8.3%
Sector Median
4.2%
Sector Avg
7.7%
How MRNA's FCF Yield compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.